Literature DB >> 15763529

Left-septal ablation of the fast pathway in AV nodal reentrant tachycardia refractory to right septal ablation.

Richard Kobza1, Gerhard Hindricks, Hildegard Tanner, Hans Kottkamp.   

Abstract

In more than 95% of patients with atrioventricular nodal reentrant tachycardia (AVNRT), curative treatment can be achieved with selective ablation of the slow pathway in the right-sided septum. We report a patient with typical AVNRT who had failed attempts to perform conventional right septal ablation of the slow as well as of the fast pathway and finally underwent successful ablation of the fast pathway on the left side of the interatrial septum using a transseptal approach.

Entities:  

Mesh:

Year:  2005        PMID: 15763529     DOI: 10.1016/j.eupc.2005.01.002

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  4 in total

1.  An approach to left septal slow pathway ablation.

Authors:  Demosthenes G Katritsis; Eleftherios Giazitzoglou; Theodoros Zografos; Kenneth A Ellenbogen; A John Camm
Journal:  J Interv Card Electrophysiol       Date:  2010-12-14       Impact factor: 1.900

2.  "Left ventricular" AV nodal reentrant tachycardia: Case report and review of the literature.

Authors:  John Green; Zaid Aziz; Hemal M Nayak; Gaurav A Upadhyay; Joshua D Moss; Roderick Tung
Journal:  HeartRhythm Case Rep       Date:  2016-07-22

3.  Catheter ablation via the left atrium for atrioventricular nodal reentrant tachycardia: A narrative review.

Authors:  Norman C Wang
Journal:  Heart Rhythm O2       Date:  2021-01-29

4.  Evaluation of the input site and characteristics of the antegrade fast pathway based on three-dimensional bi-atrial stimulus-ventricle mapping.

Authors:  Kazuhisa Matsumoto; Takeshi Tobiume; Tomomi Matsuura; Takayuki Ise; Kenya Kusunose; Koji Yamaguchi; Shusuke Yagi; Daijyu Fukuda; Tetsuzo Wakatsuki; Hirotsugu Yamada; Takeshi Soeki; Masataka Sata
Journal:  J Interv Card Electrophysiol       Date:  2021-07-07       Impact factor: 1.900

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.